Intellect Neurosciences Inc. (fka ILNS)

[qotsa55]

We will just have to agree to disagree...you read it one way and I read it another. That sentence in that PR comes after they talk about Phase 2. So to me they are talking about the phase 2 biomarkers. This shouldn't be confidential like the Pfizer/Rhinat agreements. Intellect announced the deal and the drug being developed. So Intellect should be allowed to tell its shareholders if a milestone would be paid after a phase 1 trial is complete. They never announced they would receive a milestone after phase 1. I also find it odd that Viopharma conducted another phase 1 trial since Intellect already had done one. GLTY